ストックスクリーナーアプリを入手
20.68
5.35%
1.05
Stoke Therapeutics Inc (STOK) 最新ニュース
Will Stoke Therapeutics Inc. outperform its industry peersJuly 2025 Summary & Stepwise Trade Signal Guides - خودرو بانک
Stoke Therapeutics and the Potential of Zorevunersen in Redefining Dravet Syndrome Treatment - AInvest
Stoke Therapeutics stock reaches 52-week high at 20.5 USD By Investing.com - Investing.com Canada
Is Stoke Therapeutics Inc. part of any major indexQuarterly Market Review & Fast Moving Stock Trade Plans - خودرو بانک
Why is Stoke Therapeutics Inc. stock going upMarket Growth Review & Technical Entry and Exit Tips - خودرو بانک
Will breakout in Stoke Therapeutics Inc. lead to full recoveryJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser
Is Stoke Therapeutics Inc. still worth holding after the dipRisk Management & Technical Pattern Based Buy Signals - Newser
Volume spikes in Stoke Therapeutics Inc. stock – what they mean2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Analyzing drawdowns of Stoke Therapeutics Inc. with statistical tools2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Published on: 2025-09-05 21:40:33 - خودرو بانک
Stoke Therapeutics stock reaches 52-week high at 20.5 USD - Investing.com
Price action breakdown for Stoke Therapeutics Inc.July 2025 Institutional & High Win Rate Trade Tips - Newser
Key metrics from Stoke Therapeutics Inc.’s quarterly data2025 Momentum Check & Expert Verified Movement Alerts - Newser
Applying Wyckoff theory to Stoke Therapeutics Inc. stock2025 Market Overview & Fast Moving Trade Plans - Newser
Relative strength of Stoke Therapeutics Inc. in sector analysisTrade Entry Summary & Entry Point Strategy Guides - Newser
Sector ETF performance correlation with Stoke Therapeutics Inc.Market Rally & Low Drawdown Investment Ideas - Newser
Market reaction to Stoke Therapeutics Inc.’s recent newsWeekly Gains Report & Entry Point Strategy Guides - Newser
How to use Fibonacci retracement on Stoke Therapeutics Inc.Bull Run & Free Safe Entry Trade Signal Reports - Newser
A | Is Stoke Therapeutics, Inc. a turnaround storyQuarterly Growth Report & Daily Risk Controlled Trade Plans - خودرو بانک
Can volume confirm reversal in Stoke Therapeutics Inc.Weekly Market Outlook & Precise Buy Zone Tips - Newser
What does recent volatility data suggest for Stoke Therapeutics Inc.Portfolio Update Report & Low Risk Investment Opportunities - Newser
Stoke Therapeutics Inc. recovery potential after sell off2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Will Stoke Therapeutics Inc. bounce back from current supportQuarterly Profit Review & Short-Term High Return Ideas - Newser
Insider Sell: Kaye Edward M. MD Sells 61,885 Shares of Stoke The - GuruFocus
Will Stoke Therapeutics Inc. stock go up in YEARJuly 2025 Drop Watch & Consistent Profit Trading Strategies - خودرو بانک
Institutional scanner results for Stoke Therapeutics Inc.2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Building trade automation scripts for Stoke Therapeutics Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
Stoke Therapeutics' Insider Sales: A Cautionary Tale or a Sign of Strength? - AInvest
Assessing Insider Selling Trends at Stoke Therapeutics (STOK): Liquidity Moves or Loss of Confidence? - AInvest
Stoke Therapeutics Executives Buy and Sell Shares in August and September 2025. - AInvest
Will Stoke Therapeutics Inc. benefit from rate cutsQuarterly Profit Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
What analysts say about Stoke Therapeutics Inc. stockJuly 2025 Sentiment & Precise Swing Trade Entry Alerts - خودرو بانک
Stoke Therapeutics shares fall 2.40% premarket after presenting data from Phase 1/2a and open-label extension studies of zorevunersen. - AInvest
Can a trend reversal in Stoke Therapeutics Inc. lead to recoveryIndex Update & Risk Controlled Swing Trade Alerts - Newser
What’s next for Stoke Therapeutics Inc. stock pricePortfolio Risk Summary & Stock Portfolio Risk Management - Newser
What are the risks of holding Stoke Therapeutics Inc.Quarterly Profit Summary & Long-Term Growth Portfolio Plans - خودرو بانک
Is Stoke Therapeutics Inc. stock ready for a breakoutJuly 2025 Update & Community Supported Trade Ideas - Newser
All presentations are available for download on the Stoke Therapeutics website under the Investors & News tab. - Placera
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome | BIIB - GuruFocus
Biogen and Stoke Therapeutics Announce Three-Year Results Supporting Zorevunersen's Promise for Dravet Syndrome Treatment - Quiver Quantitative
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome - The Manila Times
Biogen and Stoke Therapeutics Present Data at the 36th - GlobeNewswire
Biogen Inc. - Via Ritzau
1.40%
大文字化:
|
ボリューム (24 時間):